FTC Wins Review of Divestiture Order in Hospital Merger Case
Client Alert | 2 min read | 04.23.14
In the latest in a string of successful hospital merger challenges, the United States Court of Appeals for the Sixth Circuit recently denied ProMedica's petition for review of the FTC order requiring it to divest St. Luke's hospital.
In August 2010, ProMedica—the largest hospital provider in Lucas County, Ohio—merged with St. Luke's, an independent community hospital. The FTC challenged the merger in January 2011 and obtained an injunction from the district court that barred ProMedica from terminating St. Luke’s contracts with managed care organizations (MCOs), eliminating or transferring St. Luke's clinical services, or terminating St. Luke's employees without cause while the FTC investigated the transaction. After extensive hearings, an Administrative Law Judge and later the Federal Trade Commission itself determined that the merger would adversely affect competition in violation of Section 7 of the Clayton Act.
The Sixth Circuit found that the FTC's analysis was comprehensive, carefully reasoned, and supported by substantial evidence, particularly in both areas challenged by ProMedica. Specifically, the court agreed with the FTC practice of clustering hospital services (e.g.,various primary or secondary care services, when competitive conditions were similar for each) was an appropriate method of defining the relevant market. The court similarly found that the FTC's reliance on the Herfindahl-Hirschman Index was appropriate, given the strong correlation between market share concentration and pricing. Both the FTC and the court focused on the fact that ProMedica and St. Luke’s were the dominant providers in southwest Lucas County and thus were substitutes for managed care organizations in that area.
The merging parties' own statements, which confirmed the FTC's presumption of illegality rather than rebutted it, may have been fatal to their appeal. For example, the Court quoted St. Luke’s CEO as stating that the merger is the best path to higher hospital rates and would give the combined entity negotiating clout with insurers—a statement at odds with ProMedica's argument that its range of services, not its market share, allowed it to negotiate higher reimbursement rates. The Court also found that ProMedica failed to provide evidence of efficiencies sufficient to rebut the presumption of anticompetitive effects.
Please click here for a copy of the court's decision. ProMedica has stated that it will appeal the Sixth Circuit's ruling.
Contacts
Insights
Client Alert | 3 min read | 11.21.25
On November 7, 2025, in Thornton v. National Academy of Sciences, No. 25-cv-2155, 2025 WL 3123732 (D.D.C. Nov. 7, 2025), the District Court for the District of Columbia dismissed a False Claims Act (FCA) retaliation complaint on the basis that the plaintiff’s allegations that he was fired after blowing the whistle on purported illegally discriminatory use of federal funding was not sufficient to support his FCA claim. This case appears to be one of the first filed, and subsequently dismissed, following Deputy Attorney General Todd Blanche’s announcement of the creation of the Civil Rights Fraud Initiative on May 19, 2025, which “strongly encourages” private individuals to file lawsuits under the FCA relating to purportedly discriminatory and illegal use of federal funding for diversity, equity, and inclusion (DEI) initiatives in violation of Executive Order 14173, Ending Illegal Discrimination and Restoring Merit-Based Opportunity (Jan. 21, 2025). In this case, the court dismissed the FCA retaliation claim and rejected the argument that an organization could violate the FCA merely by “engaging in discriminatory conduct while conducting a federally funded study.” The analysis in Thornton could be a sign of how forthcoming arguments of retaliation based on reporting allegedly fraudulent DEI activity will be analyzed in the future.
Client Alert | 3 min read | 11.20.25
Client Alert | 3 min read | 11.20.25
Client Alert | 6 min read | 11.19.25

